EJCTS Click here for details of sales representative
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Gerald Buckberg
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Buckberg, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Buckberg, G.

Eur J Cardiothorac Surg 2006;30:759-761
© 2006 Elsevier Science NL

Editorial comment

Left ventricular reconstruction for dilated ischemic cardiomyopathy: biology, registry, randomization, and credibility

Gerald Buckberg*

Division of Cardiothoracic Surgery, Los Angeles UCLA School of Medicine, Los Angeles, CA 90095-1741, USA

* Tel.: +1 310 2061027; fax: +1 310 8255895. (Email: gbuckberg@mednet.ucla.edu).

The first 20% of the full text of this article appears below.

Left ventricular reconstruction or restoration shall become the emerging field of treating dilated cardiomyopathy from either ischemic causes, as in this report from the Cleveland Clinic, or subsequently from valvular and nonischemic cardiomyopathy [1], because surgical rebuilding geometrically changes the diseased spherical chamber into a more natural elliptical form. Registry data confirms collaborative information from the RESTORE multicenter cohort [2], and Dor [3] who launched this surgical evolution. Furthermore, these functional and mortality late findings are unachievable by CABG with or without mitral valve procedures [4–6].

Randomized testing is underway in the STICH trial, and the Cleveland Clinic re-establishes its vital importance by mirroring their 1978 report regarding the VA Hospital CABG trial [7]. The prior question investigated if a closed artery should be opened, whereas this article tests a comparable biologic principle by surveying mechanical changing of a diseased sphere into conical form with restoration. The original answer was to open the vessel, but revascularization results became distorted by inexperience at the VA centers (2–13% mortality with higher death rate in centers with uncommon cases) [8] compared with 1% CCF mortality in >1000 patients. Now, the . . . [Full Text of this Article]







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 2006 European Association for Cardio-Thoracic Surgery. Published by Elsevier. All rights reserved.